CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) 2025年第一季度财报(10-Q).pdf

1、 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-Q(Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31,2025 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT

2、OF 1934 For the transition period from _ to _ Commission File Number:000-53500 Creative Medical Technology Holdings,Inc.(Exact name of Registrant as specified in its charter)Nevada 87-0622284(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)211 E Osborn R

3、oad,Phoenix,AZ 85012(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code:(480)399-2822 Securities registered pursuant to Section 12(b)of the Act:Title of each class Trading Symbol(s)Name of each exchange on which registeredCommon Stock,par value$0.001 pe

4、r share CELZ The NASDAQ Stock Market LLC Indicate by check mark whether the registrant(1)has filed all reports required to be filed by section 13 or 15(d)of the Securities Exchange Act of 1934during the preceding 12 months(or for such shorter period that the registrant was required to file such repo

5、rts),and(2)has been subject to such filingrequirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically,every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)during the preceding 12 mon

6、ths(or for such shorter period that the registrant was required to submit such files).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reporting company,or anemerging growth company.See the definitions of“large a